Bellerophon Therapeutics, Inc. (BLPH) has 45 open-market insider trades by 28 insiders since 2015. The most active filer is Jonathan M. Peacock, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven B. Klinsky | 10% | — | 1 | $12.8M | 2015-02-19 |
| Matthew S. Holt | Dir10% | — | 1 | $12.8M | 2016-04-28 |
| Adam Weinstein | Dir10% | — | 1 | $12.8M | 2017-06-28 |
| Puissance Capital Management LP | Dir10% Owner | — | 2 | $10.8M | 2023-06-07 |
| Jens Luehring | Dir | — | 2 | $4.3M | 2018-06-21 |
| Linde North America, Inc. | 10% Owner | — | 1 | $4.3M | 2017-09-29 |
| Venture Partners Vi Llc Arch | 10% | — | 1 | $2.6M | 2015-02-19 |
| Robert Nelsen | Dir10% | — | 1 | $2.6M | 2015-02-19 |
| New Mountain Capital, L.L.C. | 10% Owner | — | 1 | $2.2M | 2021-03-18 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | — | 2 | $1.8M | 2019-10-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Puissance Life Science Opportunities Fund VI | 10% Owner | Sell | $215K | 2023-10-13 |
| Puissance Capital Management LP | Director & 10% Owner | Sell | $223K | 2023-06-07 |
| Bobae Kim | VP | Sell | $95K | 2023-05-18 |
| Puissance Capital Management LP | Director & 10% Owner | Sell | $10.6M | 2023-05-18 |
| New Mountain Capital, L.L.C. | 10% Owner | Sell | $2.2M | 2021-03-18 |
| Wassim Fares | Chief Medical Officer | Buy |
Companies that share insiders with BLPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $41K |
| 2020-09-10 |
| Theodore T. Wang | Director & 10% Owner | Buy | $160K | 2020-06-05 |
| Theodore T. Wang | Director & 10% | Buy | $3K | 2019-11-21 |
| Venrock Management IV, LLC | 10% | Sell | $524K | 2019-10-24 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Sell | $1.0M | 2019-10-24 |
| Theodore T. Wang | Director & 10% | Buy | $32K | 2019-06-12 |
| Theodore T. Wang | Director & 10% | Buy | $17K | 2019-05-22 |
| Theodore T. Wang | Director & 10% | Buy | $26K | 2019-05-21 |
| Fabian Tenenbaum | CEO | Buy | $3K | 2019-05-21 |
| Jonathan M. Peacock | Director | Buy | $12K | 2019-05-21 |